A single-institution phase II study indicated that combination chemotherapy using UFT (tegafur and uracil) plus cisplatin (Platinol) in patients with non-small-cell lung cancer was active with less host toxicity than other cisplatin-
Hisanobu Niitani, MD
Advertisement
Articles by Hisanobu Niitani, MD
Advertisement
Latest Updated Articles
- UFT Plus Cisplatin in Advanced Non-Small-Cell Lung Cancer: Interim Analysis of 67 Patients
Published: September 2nd 1997 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: Key Anticipated Updates in Breast and Lung Tumors
2
Anti-TIGIT Combination Therapy Yields Positive Survival in Gastric Cancers
3
Bridging Radiotherapy Prior to CAR T May Be Safe in R/R Multiple Myeloma
4
Adjuvant Chemotherapy Improves Long-Term Survival in Endometrial Cancer
5
